Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ZORN SH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 20 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Casey, DE; Zorn, SH
      The pharmacology of weight gain with antipsychotics

      JOURNAL OF CLINICAL PSYCHIATRY
    2. Mansbach, RS; Carver, J; Zorn, SH
      Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    3. Schmidt, AW; Lebel, LA; Howard, HR; Zorn, SH
      Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

      EUROPEAN JOURNAL OF PHARMACOLOGY
    4. Rollema, H; Lu, Y; Schmidt, AW; Sprouse, JS; Zorn, SH
      5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

      BIOLOGICAL PSYCHIATRY
    5. Sprouse, JS; Reynolds, LS; Braselton, JP; Rollema, H; Zorn, SH
      Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: Inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation

      NEUROPSYCHOPHARMACOLOGY
    6. FARACI WS; ZORN SH; SANNER MA; FLIRI A
      THE DISCOVERY OF POTENT AND SELECTIVE DOPAMINE-D4 RECEPTOR ANTAGONISTS

      Current opinion in chemical biology
    7. SANNER MA; CHAPPIE TA; DUNAISKIS AR; FLIRI AF; DESAI KA; ZORN SH; JACKSON ER; JOHNSON CG; MORRONE JM; SEYMOUR PA; MAJCHRZAK MJ; FARACI WS; COLLINS JL; DUIGNAN DB; DIPRETE CC; LEE JS; TROZZI A
      SYNTHESIS, SAR AND PHARMACOLOGY OF CP-293,019 - A POTENT, SELECTIVE DOPAMINE D-4 RECEPTOR ANTAGONIST

      Bioorganic & medicinal chemistry letters
    8. MANSBACH RS; BROOKS EW; SANNER MA; ZORN SH
      SELECTIVE DOPAMINE D-4 RECEPTOR ANTAGONISTS REVERSE APOMORPHINE-INDUCED BLOCKADE OF PREPULSE INHIBITION

      Psychopharmacology
    9. GUNN KP; HEYM J; ZORN SH
      ZIPRASIDONE - PRECLINICAL PROFILE OF A NEW ANTIPSYCHOTIC AGENT

      Schizophrenia research
    10. FOSSA AA; DEPASQUALE MJ; MORRONE J; ZORN SH; BRYCE D; LOWE JA; MCLEAN S
      CARDIOVASCULAR EFFECTS OF CHOLECYSTOKININ-4 ARE MEDIATED BY THE CHOLECYSTOKININ-B RECEPTOR SUBTYPE IN THE CONSCIOUS GUINEA-PIG AND DOG

      The Journal of pharmacology and experimental therapeutics
    11. ROLLEMA H; LU Y; SCHMIDT AW; ZORN SH
      CLOZAPINE INCREASES DOPAMINE RELEASE IN PREFRONTAL CORTEX BY 5-H(1)A RECEPTOR ACTIVATION

      European journal of pharmacology
    12. SCHMIDT AW; FOX CB; JACKSON ER; LAZZARO J; MCLEAN S; GANONG A; ZORN SH; SCHULZ DW; DESAI K; BRIGHT GM; HEYM J
      CP-93,393 - IN-VITRO CHARACTERIZATION OF A NOVEL ANXIOLYTIC ANTIDEPRESSANT AGENT WITH BOTH 5-HT1A AGONIST AND ALPHA-2-ADRENERGIC ANTAGONISTPROPERTIES/

      Journal of neurochemistry
    13. HOWARD HR; LOWE JA; SEEGER TF; SEYMOUR PA; ZORN SH; MALONEY PR; EWING FE; NEWMAN ME; SCHMIDT AW; FURMAN JS; ROBINSON GL; JACKSON E; JOHNSON C; MORRONE J
      3-BENZISOTHIAZOLYLPIPERAZINE DERIVATIVES AS POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENTS

      Journal of medicinal chemistry
    14. FOSSA AA; DEPASQUALE MJ; MORRONE J; ZORN SH; LOWE JH; MCLEAN S
      THE CCK-B RECEPTOR MEDIATES THE CARDIOVASCULAR EFFECTS OF CHOLECYSTOKININ-TETRAPEPTIDE (CCK-4) IN GUINEA-PIGS AND DOGS

      The FASEB journal
    15. LISTON D; WARD KM; JONES SB; ZORN SH
      CLOZAPINE IS A POTENT AGONIST AT HUMAN M4 MUSCARINIC RECEPTORS AND ANANTAGONIST AT M1, M2, M3, AND M5 RECEPTORS

      Life sciences
    16. SEEGER TF; SEYMOUR PA; SCHMIDT AW; ZORN SH; SCHULZ DW; LEBEL LA; MCLEAN S; GUANOWSKY V; HOWARD HR; LOWE JA; HEYM J
      ZIPRASIDONE (CP-88,059) - A NEW ANTIPSYCHOTIC WITH COMBINED DOPAMINE AND SEROTONIN RECEPTOR ANTAGONIST ACTIVITY

      The Journal of pharmacology and experimental therapeutics
    17. ZORN SH; JONES SB; WARD KM; LISTON DR
      CLOZAPINE IS A POTENT AND SELECTIVE MUSCARINIC M(4) RECEPTOR AGONIST

      European journal of pharmacology. Molecular pharmacology section
    18. FARACI WS; ZORN SH; BAKKER AV; JACKSON E; PRATT K
      BERYLLIUM COMPETITIVELY INHIBITS BRAIN MYOINOSITOL MONOPHOSPHATASE, BUT UNLIKE LITHIUM DOES NOT ENHANCE AGONIST-INDUCED INOSITOL PHOSPHATE ACCUMULATION

      Biochemical journal
    19. LOWE JA; DROZDA SE; SNIDER RM; LONGO KP; ZORN SH; JACKSON ER; MORRONE J; MCLEAN S; BRYCE DK; BORDNER J; NAGAHISA A; KANAI Y; SUGA O; TSUCHIYA M
      DISCOVERY OF CP-96,345 AND ITS CHARACTERIZATION IN DISEASE-MODELS INVOLVING SUBSTANCE-P

      Regulatory peptides
    20. SNIDER RM; LONGO KP; ZORN SH; MORRONE J; JACKSON ER; NAGAHISA A; KANAI Y; SUGA O; NAKAGAKI M; DROZDA SE; LOWE JA
      DIFFERENTIAL SAR OF QUINUCLIDINE SP ANTAGONISTS BETWEEN RAT AND HUMAN-TYPE RECEPTORS

      Regulatory peptides


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 00:41:36